We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




CRP Predicts Heart Problems Better than Cholesterol

By HospiMedica staff writers
Posted on 25 Nov 2002
A large landmark study has shown that a simple and inexpensive blood test for C-reactive protein (CRP) that detects inflammation is a more powerful predictor of heart problems than cholesterol screening. More...
The study was published in the November 14, 2002, issue of The New England Journal of Medicine.

The eight-year study involved 27,939 women. Of those studied who eventually suffered from heart disease, more than half had cholesterol levels considered low by current standards. When CRP evaluation was added to a cholesterol screen, the majority of these high-risk individuals were identifiable many years before their first cardiovascular event. The study confirms what researchers have suspected for years, that low-grade inflammation within the body leads to a weakening and rupture of arterial plaque and is a fundamental cause of heart attacks and strokes. CRP is a substance produced in the liver when arteries become inflamed.

"In the study, we found that individuals with high CRP but low cholesterol levels were actually at higher risk than those with high cholesterol levels but low CRP,” said Paul Ridker, M.D., lead author of the study and director of the Center for Cardiovascular Disease Prevention at Brigham and Women's Hospital (BWH, Boston, MA, USA).

"I believe measurement of CRP should be seriously evaluated as a part of our strategy for global risk prediction,” said Sidney Smith, M.D., former president of the American Heart Association. "The impact of this study, when added to existing information, makes the story very compelling.”




Related Links:
Brigham and Womens

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.